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Abstract: Inflammation affects the reliability of ferritin. The serum level of transferrin receptor protein (sTfR) represents
true demand of iron in the body. This study attempts to identify levels of sTfR and correlate the trends of sTfR/ferritin
index with BMI in the population of Karachi. 132 gender matched volunteers between the ages of 20-60 years were
recruited for this cross-sectional study. BMI was calculated using the formula: (weight in kg / height in m2). Following
groups were made according to South Asian criteria of BMI; Group A: normal weight (18.0-22.9 kg/m2), Group B:
overweight (23.0-24.9 kg/m2), Group C: obese (>25.0 kg/m2). Serum ferritin, sTfR and CRP levels were determined
using ELISA kits. Statistical comparisons were performed using Mann Whitney U and Spearman’s rank correlation,
where p<0.05 was considered significant. The results identified increased in TIBC, sTfR, ferritin and CRP in obese as
compared to normal weight individuals (p<0.001). sTfR/ferritin ratio was 0.822 which signifies increased risk of acute
myocardial infarction in group C. Serum iron (r=-0.359,p=0.004) showed negative correlation with BMI while serum
ferritin (r=0.237,p< 0.001) and sTfR (r=0.263,p= 0.036) levels were positively associated to BMI. This study highlights
a novel finding that sTfR is most likely a better clinical measure of iron status in inflammatory conditions as its
expression is effected by erythropoiesis and not by inflammation. Risk of Acute myocardial infarction can also be
predicted by increased sTfR/ferritin ratio.
Keywords: Obesity, ferritin, sTfR, inflammation, sTfR/ ferritin ratio.

INTRODUCTION
Presence of iron in hemoglobin makes its role extremely
essential to health. Low iron levels results in iron
deficiency anemia (IDA) and a decreased functional
capacity. In cardio-myopathic patients, IDA has been
commonly found to increase morbidity and mortality
(Szachniewicz et al., 2003). Iron deficiency can be
detected by detecting low levels of ferritin or increased
sTfR levels. Conventionally clinicians rely on ferritin
levels for the assessment of iron stores present in the
body.
Ferritin is a protein responsible for iron storage and a
decreased level is associated with iron deficiency.
However ferritin is an acute phase reactant that increases
in inflammatory conditions thus becoming elevated
despite normal or low iron content (Baynes et al., 1986).
Therefore, in inflammatory chronic conditions, ferritin is
an unreliable marker (Fitzsimons and Brock, 2001).
Similarly a new approach is required in diagnosing iron
deficiency in the obese population. It has been shown that
adipose tissue is responsible for secreting substances
called adipokines that cause subclinical inflammation in
obese individuals (Greenberg and Obin, 2006). In
addition it is the obese population that is more
predisposed to developing iron deficiency (Yanoff et al.,
2007). In such cases of inflammation, sTfR (soluble
Transferrin Receptors) level has been hypothesized to be
a more reliable marker for iron status (Baillie et al.,
2003). sTfR are cleavage products of the trans-membrane
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transferrin receptors expressed on the cell membrane of
iron requiring cells. The levels of sTfR in the serum
correlate with the level of receptors expressed on the cell
surfaces of iron requiring tissue, and therefore serve as a
marker for tissue iron requirement.
The debate still persists whether sTfR is a more reliable
marker as compared to ferritin in diagnosing iron
deficiency (Braga et al., 2014). Researches have tried to
observe trends of different iron parameters in their local
populations and analyzed the results to produce better cut
off ranges in order to increase specificity and sensitivity
of the above tests. Discrepancies in normal values of iron
parameters in different ethnic and geographical
populations have been recorded (Braga et al., 2014). In
this study we attempt to identify and correlate the trends
of different parameters of iron profile with the BMI
variations in the population of Karachi.

MATERIAL AND METHODS
Total of 132 apparently healthy gender matched
individuals between the ages of 20-60 year were recruited
for this cross-sectional study after being questioned about
their medical, surgical and personal history to match their
compatibility with the inclusion of this study. Exclusion
criteria included all conditions which led to change in the
body iron stores or cause inflammation, such as
pregnancy, smoking, alcoholism, hemoglobinopathies,
diabetes mellitus, bleeding disorders, any acute illness
during last 1 month, as well as iron deficiency as seen on
complete blood picture (CP).
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Table 1: Biophysical & Biochemical Parameters of the Study Subjects
Variable
Age (year)
BMI (kg/m2 )
Waist to Hip ratio
Haemoglobin (g/dl)
Ferritin (ng/dl)
Iron (mg/dl)
TIBC ( µg/dl)
Transferrin Saturation (%)
sTfR (mg/l)
CRP (mg/dl)
sTfR/Ferritin ratio

Group A Normal
Mean ± SD (n=44)
36.59 ± 7.27
21.41 ± 1.93
0.89 ± 0.11
13.11 ± 1.84
11.25 ± 7.60
2.18 ± 1.42
1.94 ± 1.08
50 ± 8.90
6.88 ± 0.68
3.48 ± 5.33
0.61

Group B Overweight
Mean ± SD (n=44)
35.1±3.62
24.3±0.55
0.85±0.11
12.8±1.56
19.3±12.8*
2.25±3.00
1.62±0.30*
45.6±7.20
8.07±4.58
4.25±0.59
0.42

Group C Obese
Mean ± SD (n=44)
34.43 ± 8.16
29.99 ± 4.16
0.88 ± 0.08
10 ± 1.53*
22.8 ± 22.46*
1.08 ± 1.28*
3.31 ± 0.78*
20.23 ± 2.10*
18.76 ± 0.75#
8.96 ± 5.33*
0.822#

p value
>0.05
<0.001
>0.05
0.02
<0.001
<0.001
<0.001
<0.001
>0.001
<0.001
<0.001

Where: BMI (Body mass index), TIBC (total iron binding capacity), sTfR (serum transferrin receptor protein) & CRP (C-reactive
protein). P value <0.05 considered statistically significant
*statistically significant when compared to group A
#
statistically significant when compared to group A & B

The research protocol was permitted by the research
ethics committee, Basic Medical Sciences Institute,
Jinnah Postgraduate Medical Centre, (No. F.12/2013/BMSI-E.COMT/007/JPMC). All the participants
were asked to complete a verbal and written informed
consent.
BMI was calculated using the formula: (weight in kg /
height in m2) (Garrow and Webster, 1984) after
measuring weight and height of all the subjects in
kilograms and meters respectively, using Stadiometer (ZT
-120 Health Scale, made in China). The Hip and waist
circumference was measured by standard techniques
(World Health, 2011).The subjects were divided into;
Group A: normal weight (18.0-22.9 kg/m2), Group B:
overweight (23.0-24.9 kg/m2), Group C: obese (>25.0
kg/m2) according to South Asian criteria of BMI
(Sharma, 2013, Singh et al., 2008).
Serum ferritin, sTfR and CRP levels in serum samples
were determined using a commercially available
sandwich ELISA kit (cat # YHB2785Hu; BioCheck
(Foster city, CA, USA, cat #. BC- 1025) and Dia Source,
(Immunoassay SA. Belgium, ref # KAPDB4360,
respectively.
Statistical analysis of the data was achieved using the
SPSS for Windows 19 software package (SPSS Inc.,
Chicago, IL). A descriptive statistical analysis of
continuous variables was performed. Data on continuous
variables i.e. biophysical and biochemical parameters
were presented as Mean + Standard Deviation (SD).
Statistical comparisons were performed by using Mann
Whitney U test for non-parametric variables. Associations
between circulating sTfR levels and BMI were
determined using Spearman’s rank correlation.
Associations were considered significant if P < 0.05.
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RESULTS
A total of 132 subjects were divided into Group A, B, C
according to their BMI with reference to the South Asian
Criteria (Sharma, 2013, Singh et al., 2008).
Biophysical parameters
Mean age of the study subjects was 24.7 ± 6.34 years and
mean BMI was 17.9 ± 2.21 kg/m2. A trend of raised BMI
was seen from group A–C (p=<0.001), whereas no
significant change was noted in WHR in the study groups
(p=>0.5) (table 1).
Biochemical parameters
There was a significant decrement in the hemoglobin
levels (p= 0.02); serum iron levels (p < 0.001) and
Transferrin saturation (p<0.001) from group A-C. TIBC
and serum transferrin receptor protein on the other hand
demonstrate a rise in group C when compared to Group A
(p<0.001). This depicts a true picture of iron deficiency in
Group C. Unexpectedly, serum ferritin levels were
elevated in both group B and C as compared to the group
A (p<0.001), respectively. In group C, sTfR/ferritin ratio
was also calculated to be 0.822 which is suggestive of
increased risk of acute myocardial infarction in obese
individuals. CRP also showed a great surge in group C
individuals as compared to group A individuals (p<0.001)
(table 1). Spearman rank correlation portrayed a negative
correlation of serum iron (r=-0.359, p=0.004) with BMI
while serum ferritin (r=0.237, p< 0.001) and sTfR
(r=0.263, p= 0.036) levels were positively associated to
BMI (fig I A-C).

DISCUSSION
The study was focused on assessment of serum transferrin
receptor (sTfR) levels in specific BMI groups with
Pak. J. Pharm. Sci., Vol.30, No.2, March 2017, pp.537-540
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Fig. 1: Correlation of BMI with Iron Parameters

In this study the sTfR levels are elevated in obese group
individuals although, the individuals did not have any
apparent iron deficiency (table 1), which was initially
confirmed by the microscopic picture. So far the sTfR cut
off levels are not well documented in South Asian
population, this study is highlighting the levels of sTfR in
Pakistani population. The increased sTfR levels in this
study indicate the functional picture of iron in the body.
This suggests that the demand of iron is more in obese
individuals probably because the iron is sequestered
within the macrophages and as a result sTfR increases to
fulfill the demand.

an excess of adipocytes means additional adipokine in
circulation hence the body enters a state of sub-clinical
inflammation. This leads to a decrease in iron levels of
the body due to the inflammatory mediated sequestration
of iron within the reticulo-endothelial system (Karl et al.,
2009). Although the increase in ferritin level trend may
seem vague but as identified by anoother study of our
group; its levels increase when the body is in a state of
subclinical inflammation such as obesity (Alam et al.,
2014) . Given that it could be postulated that ferritin is
responsible for giving false positive results for IDA in
overweight and obese (fig. 1B) and thus, sTfR is likely to
be the best clinical measure of iron status in these subjects
as its expression is not effected by inflammation but
demand of erythropoiesis by the body (Zimmermann,
2008) (fig. 1A and C).

The results of this study show that the serum ferritin
levels of obese were higher than those of overweight
individuals. It was also seen that with an increase in BMI
there is a corresponding increase in the C reactive protein
(CRP) in the body (Table 1). CRP is an acute phase
reactant that is produced by the liver under the influence
of adipokine released by the adipocytes in the body (Alam
et al., 2014, Brooks et al., 2010, Choi et al., 2013). Since

Obesity is one of the causes of increased risk for acute
myocardial infarction (AMI). Furthermore, some studies
have established increased serum ferritin as a risk factor
for AMI (Holay et al., 2012). Recently attention has been
given to evaluate whether sTfR/ferritin ratio can be used
as a better marker in certain conditions including AMI. A
ratio of sTfR and Ferritin provides highest sensitivity and
specificity in this regards (Punnonen et al., 1997). The

reference to South Asian criteria and finding out whether
the serum transferrin receptor level is a better marker of
iron status compared to ferritin levels.
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current study shows that sTfR/ferritin levels in obese
group is almost near 1 (0.822), that is it is increasing from
normal weight to obese individuals. sTfR and ferritin ratio
has been studied in different patients of coronary artery
diseases (CAD) elucidating an increase in sTfR and
ferritin ratio as the disease progresses from stable angina
to the potentially life taking AMI (Braun et al., 2004).
Hence it is logical to conclude that an increase in sTfR to
ferritin ratio can be a good predictor of AMI in our obese
subjects.
The limitation of this study has been its cross-sectional
design; prospective studies would be a better evaluator.
Relatively larger population studies are not available to
define the cut off values of the iron parameters Pakistani
population. However, this study proposes a causal
connection between change in BMI, inflammation and
low iron levels.

CONCLUSION
This study highlights a novel finding of increasing levels
of sTfR in obese Pakistani population. On the contrary
ferritin levels could not depict the true iron deficient
status. It could be postulated that sTfR is likely to be the
best clinical measure of iron status in obese subjects. sTfR
is most likely a better clinical measure of iron status in
inflammatory conditions as its expression is effected by
erythropoiesis and not by inflammation. Furthermore; risk
of acute myocardial infarction can also be predicted by
increased sTfR/ferritin ratio.
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